BIO-RAD LABORATORIES INC
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BIO-RAD LABORATORIES, INC. | |
|---|---|
| By: | /s/ Norman Schwartz |
| Norman Schwartz | |
| Chairman of the Board and Chief Executive Officer | |
| Date: | February 14, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Principal Executive Officer: | ||
|---|---|---|
| /s/ Norman Schwartz | Chairman of the Board and | February 14, 2025 |
| (Norman Schwartz) | Chief Executive Officer | |
| Principal Financial Officer and | ||
| Principal Accounting Officer: | ||
| /s/ Roop K. Lakkaraju | Executive Vice President, | |
| (Roop K. Lakkaraju) | Chief Financial Officer | February 14, 2025 |
| Other Directors: | ||
| /s/ Jeffrey L. Edwards | Director | February 14, 2025 |
| (Jeffrey L. Edwards) | ||
| /s/ Gregory K. Hinckley | Director | February 14, 2025 |
| (Gregory K. Hinckley) | ||
| /s/ Melinda Litherland | Director | February 14, 2025 |
| (Melinda Litherland) | ||
| /s/ Arnold A. Pinkston | Director | February 14, 2025 |
| (Arnold A. Pinkston) | ||
| /s/ Allison Schwartz | Director | February 14, 2025 |
| (Allison Schwartz) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.